Mayne Renews Crusade For Colon Cancer Drug
On the heels of several suits Sanofi-Aventis U.S. LLC has launched against generics over the blockbuster cancer drug Eloxatin, Mayne Pharma Ltd. filed a suit for judgment of noninfringement of Sanofi's...To view the full article, register now.
Already a subscriber? Click here to view full article